Granahan Investment Management - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$10,190,924
+483.0%
398,862
+515.0%
0.36%
+744.2%
Q1 2022$1,748,000
-14.8%
64,851
+17.0%
0.04%
+2.4%
Q4 2021$2,051,000
-41.3%
55,405
-24.3%
0.04%
-36.4%
Q3 2021$3,496,00073,1770.07%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 253,300$6,829,0007.22%
Integral Health Asset Management, LLC 125,000$3,370,0000.88%
Green Alpha Advisors, LLC 23,013$620,0000.42%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 24,915$672,0000.41%
Nikko Asset Management Americas, Inc. 1,402,078$37,856,0000.28%
ARK Investment Management 2,383,840$64,268,0000.27%
FEDERATED HERMES, INC. 3,761,900$101,421,0000.23%
PDT Partners, LLC 49,500$1,335,0000.12%
NinePointTwo Capital LLC 12,417$334,0000.09%
Hennion & Walsh Asset Management, Inc. 59,385$1,601,0000.08%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders